A paper published today in the Journal of the National Cancer Institute brings new focus to the questions already raised about prostate cancer screening.
Prostate Cancer Screening Shows No Benefit – New York Times
“Updated findings from one of the largest studies of prostate cancer screening show that the commonly used P.S.A. blood test did not save lives, although questions remain about whether younger men or those at very high risk for the disease might benefit.”
“It doesn’t seem as if the PSA has any impact on mortality or death,” says Thomas Kirk, president of Us TOO, a patient advocacy group not involved in the new study, which included 76,685 men ages 55 to 74. “It would be nice if we could say that a PSA screening could save your life, but we can’t say that.”
Study: Routine prostate cancer testing does not save lives – The Washington Post
“There is tendency to believe that if a test finds disease, that must be a good thing,” said Otis Brawley, a cancer screening expert and chief medical officer of the American Cancer Society. But that isn’t necessarily so, he said, adding, “I’m very worried about ‘auditorium medicine,’ where a long line of guys waits to get screened and there is no discussion or education about the potential risks and benefits.”
PSA screening doesn’t prevent cancer deaths: study – Reuters Health
Comparing men who were screened each year with so-called PSA tests, for prostate specific antigen, or rectal exams to those who received their usual care, researchers found that more men in the screening group had been diagnosed with prostate cancer after 13 years — but there was no difference in how many had died from it.